The journal of nutrition, health & aging

, Volume 23, Issue 1, pp 102–104 | Cite as

Assessment of Cognitive Impairment in Patients with Chronic Obstructive Pulmonary Disease Using the Rapid Cognitive Screen

  • Edward CharbekEmail author
  • K. Huynh
  • E. Kim
  • R. P. Nayak



To determine the prevalence of cognitive impairment in chronic obstructive pulmonary disease (COPD) patients using the Rapid Cognitive Screen (RCS).


Cross sectional study.


A total of 106 men and women with COPD 50 years of age or older. Setting: Pulmonary ambulatory clinic in a tertiary academic center in St. Louis, Missouri, USA.


We enrolled patients with COPD who completed the RCS tool. Patients were classified as having normal cognition, mild cognitive impairment (MCI), or dementia if they scored ≥ 8, 6–7, or ≤ 5, respectively. The prevalence of each category was measured, and patients’ baseline characteristics were compared.


One hundred and six patients completed the RCS. Of those, 36 (33.9%) patients scored ≤ 5 on the RCS, 33 (31.1%) scored 6 or 7, and 37 (34.9%) scored ≥ 8. The prevalence of dementia, MCI, and normal cognition were 33.9%, 31.1%, and 34.9%, respectively. Baseline lung function was not different between patients with normal cognition and those with abnormal cognition (FEV1 1.53 ± 0.39 vs 1.45 ± 0.32 L). In patients with abnormal cognition, there was no difference in patients’ characteristics between patients with MCI or dementia.


Cognitive impairment is highly prevalent in patients with COPD. RCS successfully identified cognitive impairment in COPD. We recommend performing RCS in patients with COPD routinely.

Key words

COPD cognitive dysfunction dementia Rapid Cognitive Screen 


  1. 1.
    Divo MJ, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta JJ, Cabrera C, Zagaceta J, Sanchez-Salcedo P, Berto J, Davila RB, Alcaide AB, Cote C, Celli BR, BODE Collaborative Group. COPD comorbidities network. Eur Respir J 2015;46:640–650.CrossRefGoogle Scholar
  2. 2.
    Singh B, Parsaik AK, Mielke MM, Roberts RO, Scanlon PD, Geda YE, Pankratz VS, Christianson T, Yawn BP, Petersen RC. Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clin Proc 2013;88:1222–1230.CrossRefGoogle Scholar
  3. 3.
    Chrystyn H, van der Palen J, Sharma R, Barnes N, Delafont B, Mahajan A, Thomas M. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med 2017;27:22.CrossRefGoogle Scholar
  4. 4.
    Malmstrom TK, Voss VB, Cruz-Oliver DM, Cummings-Vaughn LA, Tumosa N, Grossberg GT, Morley JE. The Rapid Cognitive Screen (RCS): A Point-of-Care Screening for Dementia and Mild Cognitive Impairment. J Nutr Health Aging 2015;19:741–744.CrossRefGoogle Scholar
  5. 5.
    Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DMG, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 2017;195:557–582.Google Scholar
  6. 6.
    Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648–654.CrossRefGoogle Scholar
  7. 7.
    Jones PW. COPD Assessment Test–Rationale, Development, Validation and Performance. COPD: Journal of Chronic Obstructive Pulmonary Disease 2013;10:269–271.CrossRefGoogle Scholar
  8. 8.
    De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006;80:219–227.CrossRefGoogle Scholar
  9. 9.
    Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:549–555.CrossRefGoogle Scholar
  10. 10.
    Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel P-R, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir Rev 2015;24:159–172.CrossRefGoogle Scholar
  11. 11.
    Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 2010;35:913–922.CrossRefGoogle Scholar
  12. 12.
    Grant I. Neuropsychologic Findings in Hypoxemic Chronic Obstructive Pulmonary Disease. Arch Intern Med 1982;142:1470.CrossRefGoogle Scholar
  13. 13.
    Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive Dysfunction in Patients Hospitalized With Acute Exacerbation of COPD. Chest 2013;144:119–127.CrossRefGoogle Scholar
  14. 14.
    Goldstein PC. Drawing Impairment Predicts Mortality in Severe COPD. Chest 2007;132:1411–1412.CrossRefGoogle Scholar
  15. 15.
    Lareau SC, Hodder R. Teaching inhaler use in chronic obstructive pulmonary disease patients. J Am Acad Nurse Pract 2011;24:113–120.CrossRefGoogle Scholar
  16. 16.
    Incalzi RA, Gemma A, Marra C, Capparella O, Fuso L, Carbonin P. Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest 1997;112:1506–1513.CrossRefGoogle Scholar
  17. 17.
    National Clinical Guideline Centre (UK). Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. London: Royal College of Physicians (UK); 2012.Google Scholar

Copyright information

© Serdi and Springer-Verlag France SAS, part of Springer Nature 2018

Authors and Affiliations

  • Edward Charbek
    • 1
    Email author
  • K. Huynh
    • 1
  • E. Kim
    • 1
  • R. P. Nayak
    • 1
  1. 1.From the Division of pulmonary, Critical Care, and Sleep MedicineSaint Louis University School of MedicineSt. LouisUSA

Personalised recommendations